Targeting YAP and Hippo signaling pathway in liver cancer

Bibliography

• Oh H, Irvine KD. Yorkie: the final destination of Hippo signaling. Trends Cell Biol 2010: published online 7 May 2010, doi:10.1016/j.tcb.2010.04.005
   Google Scholar
• Saucedo LJ, Edgar BA. Filling out the Hippo pathway. Nat Rev Mol Cell Biol 2007;8:613-21
   PubMed Web of Science ®Google Scholar
• Overholtzer M, Zhang J, Smolen GA, Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci USA 2006;103:12405-10
   PubMed Web of Science ®Google Scholar
• Zender L, Spector MS, Xue W, Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006;125:1253-67
   PubMed Web of Science ®Google Scholar
• Zhao B, Wei X, Li W, Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 2007;21:2747-61
   PubMed Web of Science ®Google Scholar
• Dong J, Feldmann G, Huang J, Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007;130:1120-33
   PubMed Web of Science ®Google Scholar
• Justice RW, Zilian O, Woods DF, The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev 1995;9:534-46
   PubMed Web of Science ®Google Scholar
• Tapon N, Harvey KF, Bell DW, Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 2002;110:467-78
   PubMed Web of Science ®Google Scholar
• Kango-Singh M, Nolo R, Tao C, Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development 2002;129:5719-30
   PubMedGoogle Scholar
• Harvey KF, Pfleger CM, Hariharan IK. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 2003;114:457-67
   PubMed Web of Science ®Google Scholar
• Pantalacci S, Tapon N, Leopold P. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat Cell Biol 2003;5:921-7
   PubMed Web of Science ®Google Scholar
• Udan RS, Kango-Singh M, Nolo R, Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol 2003;5:914-20
   PubMed Web of Science ®Google Scholar
• Wu S, Huang J, Dong J, Pan D. Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 2003;114:445-56
   PubMed Web of Science ®Google Scholar
• Lai ZC, Wei X, Shimizu T, Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 2005;120:675-85
   PubMed Web of Science ®Google Scholar
• Huang J, Wu S, Barrera J, The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 2005;122:421-34
   PubMed Web of Science ®Google Scholar
• Oh H, Irvine KD. In vivo analysis of Yorkie phosphorylation sites. Oncogene 2009;28:1916-27
   Google Scholar
• Goulev Y, Fauny JD, Gonzalez-Marti B, SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila. Curr Biol 2008;18:435-41
   PubMed Web of Science ®Google Scholar
• Wu S, Liu Y, Zheng Y, The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell 2008;14:388-98
   Google Scholar
• Peng HW, Slattery M, Mann RS. Transcription factor choice in the Hippo signaling pathway: homothorax and yorkie regulation of the microRNA bantam in the progenitor domain of the Drosophila eye imaginal disc. Genes Dev 2009;23:2307-19
   PubMed Web of Science ®Google Scholar
• Thompson BJ, Cohen SM. The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila. Cell 2006;126:767-74
   PubMed Web of Science ®Google Scholar
• Nolo R, Morrison CM, Tao C, The bantam microRNA is a target of the hippo tumor-suppressor pathway. Curr Biol 2006;16:1895-904
   PubMed Web of Science ®Google Scholar
• Hamaratoglu F, Willecke M, Kango-Singh M, The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nat Cell Biol 2006;8:27-36
   PubMed Web of Science ®Google Scholar
• Genevet A, Wehr MC, Brain R, Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev Cell 2010;18:300-8
   PubMed Web of Science ®Google Scholar
• Bennett FC, Harvey KF. Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway. Curr Biol 2006;16:2101-10
   Google Scholar
• Silva E, Tsatskis Y, Gardano L, The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway. Curr Biol 2006;16:2081-9
   PubMedGoogle Scholar
• Willecke M, Hamaratoglu F, Kango-Singh M, The fat cadherin acts through the hippo tumor-suppressor pathway to regulate tissue size. Curr Biol 2006;16:2090-100
   PubMedGoogle Scholar
• Mahoney PA, Weber U, Onofrechuk P, The fat tumor suppressor gene in Drosophila encodes a novel member of the cadherin gene superfamily. Cell 1991;67:853-68
   PubMed Web of Science ®Google Scholar
• Cho E, Irvine KD. Action of fat, four-jointed, dachsous and dachs in distal-to-proximal wing signaling. Development 2004;131:4489-500
   PubMedGoogle Scholar
• Brittle AL, Repiso A, Casal J, Four-jointed modulates growth and planar polarity by reducing the affinity of dachsous for fat. Curr Biol 2010;20:803-10
   PubMed Web of Science ®Google Scholar
• Simon MA, Xu A, Ishikawa HO, Irvine KD. Modulation of FAt: dachsous binding by the cadherin domain kinase four-jointed. Curr Biol 2010;20:811-7
   PubMedGoogle Scholar
• Mao Y, Rauskolb C, Cho E, Dachs: an unconventional myosin that functions downstream of Fat to regulate growth, affinity and gene expression in Drosophila. Development 2006;133:2539-51
   Google Scholar
• Cho E, Feng Y, Rauskolb C, Delineation of a fat tumor suppressor pathway. Nat Genet 2006;38:1142-50
   PubMed Web of Science ®Google Scholar
• McCartney BM, Kulikauskas RM, LaJeunesse DR, Fehon RG. The neurofibromatosis-2 homologue, Merlin, and the tumor suppressor expanded function together in Drosophila to regulate cell proliferation and differentiation. Development 2000;127:1315-24
   PubMedGoogle Scholar
• Polesello C, Huelsmann S, Brown NH, Tapon N. The Drosophila RASSF homolog antagonizes the hippo pathway. Curr Biol 2006;16:2459-65
   PubMed Web of Science ®Google Scholar
• Baumgartner R, Poernbacher I, Buser N, The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev Cell 2010;18:309-16
   PubMed Web of Science ®Google Scholar
• Yu J, Zheng Y, Dong J, Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev Cell 2010;18:288-99
   PubMed Web of Science ®Google Scholar
• Grzeschik NA, Parsons LM, Allott ML, Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms. Curr Biol 2010;20:573-81
   PubMed Web of Science ®Google Scholar
• Robinson BS, Huang J, Hong Y, Moberg KH. Crumbs regulates Salvador/Warts/Hippo signaling in Drosophila via the FERM-domain protein expanded. Curr Biol 2010;20:582-90
   PubMed Web of Science ®Google Scholar
• Tao W, Zhang S, Turenchalk GS, Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity. Nat Genet 1999;21:177-81
   PubMed Web of Science ®Google Scholar
• Callus BA, Verhagen AM, Vaux DL. Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J 2006;273:4264-76
   PubMed Web of Science ®Google Scholar
• Chan EH, Nousiainen M, Chalamalasetty RB, The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 2005;24:2076-86
   PubMed Web of Science ®Google Scholar
• Praskova M, Xia F, Avruch J. MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr Biol 2008;18:311-21
   PubMedGoogle Scholar
• Hao Y, Chun A, Cheung K, Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem 2008;283:5496-509
   PubMed Web of Science ®Google Scholar
• Lei QY, Zhang H, Zhao B, TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol 2008;28:2426-36
   PubMed Web of Science ®Google Scholar
• Qi C, Zhu YT, Hu L, Zhu Y-J. Identification of Fat4 as a candidate tumor suppressor gene in breast cancers. Int J Cancer 2009;124:793-8
   PubMed Web of Science ®Google Scholar
• Lau YK, Murray LB, Houshmandi SS, Merlin is a potent inhibitor of glioma growth. Cancer Res 2008;68(14):5733-42
   PubMedGoogle Scholar
• Morrison H, Sperka T, Manent J, Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac. Cancer Res 2007;67:520-7
   PubMed Web of Science ®Google Scholar
• Ikeda M, Kawata A, Nishikawa M, Hippo pathway-dependent and -independent roles of RASSF6. Sci Signal 2009;2(90):ra59
   PubMedGoogle Scholar
• Cooper WN, Hesson LB, Matallanas D, RASSF2 associates with and stabilizes the proapoptotic kinase MST2. Oncogene 2009;28:2988-98
   PubMedGoogle Scholar
• Sudol M, Bork P, Einbond A, Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel protein module, the WW domain. J Biol Chem 1995;270:14733-41
   PubMed Web of Science ®Google Scholar
• Sudol M. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene 1994;9:2145-52
   PubMed Web of Science ®Google Scholar
• Komuro A, Nagai M, Navin NE, Sudol M. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem 2003;278:33334-41
   PubMed Web of Science ®Google Scholar
• Chen HI, Sudol M. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc Natl Acad Sci USA 1995;92:7819-23
   PubMedGoogle Scholar
• Bork P, Sudol M. The WW domain: a signalling site in dystrophin? Trends Biochem Sci 1994;19:531-3
   PubMed Web of Science ®Google Scholar
• Hoshino M, Qi M-L, Yoshimura N, Transcriptional repression induces a slowly progressive atypical neuronal death associated with changes of YAP isoforms and p73. J Cell Biol 2006;172:589-604
   PubMedGoogle Scholar
• Zhao B, Li L, Tumaneng K, A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFbeta-TRCP. Genes Dev 2010;24:72-85
   PubMed Web of Science ®Google Scholar
• Kanai F, Marignani PA, Sarbassova D, TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J 2000;19:6778-91
   PubMed Web of Science ®Google Scholar
• Oka T, Sudol M. Nuclear localization and pro-apoptotic signaling of YAP2 require intact PDZ-binding motif. Genes Cells 2009;14:607-15
   Google Scholar
• Danovi SA, Rossi M, Gudmundsdottir K, Yes-associated protein (YAP) is a critical mediator of c-Jun-dependent apoptosis. Cell Death Differ 2008;15:217-9
   Google Scholar
• Strano S, Monti O, Pediconi N, The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA damage. Mol Cell 2005;18:447-59
   PubMed Web of Science ®Google Scholar
• Levy D, Adamovich Y, Reuven N, Shaul Y. The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73. Cell Death Differ 2007;14:743-51
   PubMedGoogle Scholar
• Zagurovskaya M, Shareef MM, Das A, EGR-1 forms a complex with YAP-1 and upregulates Bax expression in irradiated prostate carcinoma cells. Oncogene 2009;28:1121-31
   PubMed Web of Science ®Google Scholar
• Strano S, Munarriz E, Rossi M, Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J Biol Chem 2001;276:15164-73
   PubMed Web of Science ®Google Scholar
• Zaidi SK, Sullivan AJ, Medina R, Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J 2004;23:790-9
   PubMed Web of Science ®Google Scholar
• Teplyuk NM, Galindo M, Teplyuk VI, Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors. J Biol Chem 2008;283:27585-97
   PubMed Web of Science ®Google Scholar
• Vassilev A, Kaneko KJ, Shu H, TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev 2001;15:1229-41
   PubMed Web of Science ®Google Scholar
• Zhang X, Milton CC, Humbert PO, Harvey KF. Transcriptional output of the Salvador/warts/hippo pathway is controlled in distinct fashions in Drosophila melanogaster and mammalian cell lines. Cancer Res 2009;69:6033-41
   PubMedGoogle Scholar
• Chen L, Chan SW, Zhang X, Structural basis of YAP recognition by TEAD4 in the hippo pathway. Genes Dev 2010;24:290-300
   Google Scholar
• Li Z, Zhao B, Wang P, Structural insights into the YAP and TEAD complex. Genes Dev 2010;24:235-40
   PubMed Web of Science ®Google Scholar
• Zhao B, Kim J, Ye X, Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein. Cancer Res 2009;69:1089-98
   PubMedGoogle Scholar
• Zhao B, Ye X, Yu J, TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 2008;22:1962-71
   PubMed Web of Science ®Google Scholar
• Chan SW, Lim CJ, Loo LS, TEADs mediate nuclear retention of TAZ to promote oncogenic transformation. J Biol Chem 2009;284:14347-58
   PubMed Web of Science ®Google Scholar
• Hong JH, Hwang ES, McManus MT, TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 2005;309:1074-8
   PubMed Web of Science ®Google Scholar
• Steinhardt AA, Gayyed MF, Klein AP, Expression of Yes-associated protein in common solid tumors. Hum Pathol 2008;39:1582-9
   PubMed Web of Science ®Google Scholar
• Fernandez-L A, Northcott PA, Dalton J, YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic Hedgehog-driven neural precursor proliferation. Genes Dev 2009;23:2729-41
   Google Scholar
• Camargo FD, Gokhale S, Johnnidis JB, YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 2007;17:2054-60
   PubMed Web of Science ®Google Scholar
• Xu MZ, Yao TJ, Lee NP, Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 2009;115:4576-85
   PubMed Web of Science ®Google Scholar
• Wang Y, Dong Q, Zhang Q, Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci 2010: published online 10 March 2010, doi; 10.1111/j.1349-7006.2010.01511
   Google Scholar
• Lam-Himlin DM, Daniels JA, Gayyed MF, The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway. Int J Gastrointest Cancer 2006;37:103-9
   PubMedGoogle Scholar
• Yuan M, Tomlinson V, Lara R, Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ 2008;15:1752-9
   PubMed Web of Science ®Google Scholar
• Kawahara M, Hori T, Chonabayashi K, Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73. Blood 2008;112:3856-66
   PubMedGoogle Scholar
• Basu S, Totty NF, Irwin MS, Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell 2003;11:11-23
   PubMed Web of Science ®Google Scholar
• Guo C, Tommasi S, Liu L, RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. Curr Biol 2007;17:700-5
   PubMed Web of Science ®Google Scholar
• Matallanas D, Romano D, Yee K, RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol Cell 2007;27:962-75
   PubMed Web of Science ®Google Scholar
• Oka T, Mazack V, Sudol M. Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). J Biol Chem 2008;283:27534-46
   PubMed Web of Science ®Google Scholar
• Tomlinson V, Gudmundsdottir K, Luong P, JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis. Cell Death and Dis 2010;1(2):e29
   Google Scholar
• Yuan M, Luong P, Hudson C, c-Abl phosphorylation of DeltaNp63alpha is critical for cell viability. Cell Death and Dis 2010;1(1):e16
   Google Scholar
• St John MA, Tao W, Fei X, Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat Genet 1999;21:182-6
   PubMed Web of Science ®Google Scholar
• Hisaoka M, Tanaka A, Hashimoto H. Molecular alterations of h-warts/LATS1 tumor suppressor in human soft tissue sarcoma. Lab Invest 2002;82:1427-35
   PubMedGoogle Scholar
• Jiang Z, Li X, Hu J, Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma. Neurosci Res 2006;56:450-8
   PubMed Web of Science ®Google Scholar
• Morinaga N, Shitara Y, Yanagita Y, Molecular analysis of the h-warts/LATS1 gene in human breast cancer. Int J Oncol 2000;17:1125-9
   PubMedGoogle Scholar
• Takahashi Y, Miyoshi Y, Takahata C, Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Clin Cancer Res 2005;11:1380-5
   PubMed Web of Science ®Google Scholar
• Xia H, Qi H, Li Y, LATS1 tumor suppressor regulates G2/M transition and apoptosis. Oncogene 2002;21:1233-41
   PubMed Web of Science ®Google Scholar
• Yang X, Li DM, Chen W, Xu T. Human homologue of Drosophila lats, LATS1, negatively regulate growth by inducing G2/M arrest or apoptosis. Oncogene 2001;20(45):6516-23
   PubMedGoogle Scholar
• Seidel C, Schagdarsurengin U, Blumke K, Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma. Mol Carcinog 2007;46:865-71
   PubMed Web of Science ®Google Scholar
• Minoo P, Zlobec I, Baker K, Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer. Mod Pathol 2007;20:331-8
   PubMed Web of Science ®Google Scholar
• Zhou D, Conrad C, Xia F, Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 2009;16:425-38
   PubMed Web of Science ®Google Scholar
• Lu L, Li Y, Kim SM, Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA 2010;107:1437-42
   PubMed Web of Science ®Google Scholar
• Song H, Mak KK, Topol L, Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA 2010;107:1431-6
   PubMed Web of Science ®Google Scholar
• Oh HJ, Lee KK, Song SJ, Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis. Cancer Res 2006;66:2562-9
   PubMedGoogle Scholar
• Luo X, Li Z, Yan Q, The human WW45 protein enhances MST1-mediated apoptosis in vivo. Int J Mol Med 2009;23:357-62
   PubMedGoogle Scholar
• Lee JH, Kim TS, Yang TH, A crucial role of WW45 in developing epithelial tissues in the mouse. EMBO J 2008;27:1231-42
   PubMedGoogle Scholar
• Lee KP, Lee JH, Kim TS, The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci USA 2010;107:8248-53
   PubMed Web of Science ®Google Scholar
• Asthagiri AR, Parry DM, Butman JA, Neurofibromatosis type 2. Lancet 2009;373:1974-86
   PubMed Web of Science ®Google Scholar
• Harvey K, Tapon N. The Salvador-Warts-Hippo pathway – an emerging tumour-suppressor network. Nat Rev Cancer 2007;7:182-91
   PubMed Web of Science ®Google Scholar
• Liu AM, Poon RT, Luk JM. MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun 2010;394:623-7
   PubMed Web of Science ®Google Scholar
• Cao X, Pfaff SL, Gage FH. YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes Dev 2008;22:3320-34
   PubMed Web of Science ®Google Scholar
• Ota M, Sasaki H. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development 2008;135:4059-69
   PubMedGoogle Scholar
• Tian W, Yu J, Tomchick DR, Structural and functional analysis of the YAP-binding domain of human TEAD2. Proc Natl Acad Sci USA 2010;107:7293-8
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu CY, Zha ZY, TEAD Transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J Biol Chem 2009;284:13355-62
   PubMed Web of Science ®Google Scholar
• Wang MY, Chen PS, Prakash E, Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1. Cancer Res 2009;69:3482-91
   Google Scholar
• Xie D, Nakachi K, Wang H, Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 2001;61:8917-23
   PubMed Web of Science ®Google Scholar
• Dornhofer N, Spong S, Bennewith K, Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis. Cancer Res 2006;66:5816-27
   PubMedGoogle Scholar
• Deng YZ, Chen PP, Wang Y, Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling. J Biol Chem 2007;282:36571-81
   PubMed Web of Science ®Google Scholar
• Lay JD, Hong CC, Huang JS, Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL. Cancer Res 2007;67:3878-87
   PubMed Web of Science ®Google Scholar
• Zhang YX, Knyazev PG, Cheburkin YV, AXL is a potential target for therapeutic intervention in breast cancer progression. Cancer Res 2008;68:1905-15
   PubMed Web of Science ®Google Scholar
• Alexia C, Fallot G, Lasfer M, An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis. Biochem Pharmacol 2004;68:1003-15
   PubMed Web of Science ®Google Scholar
• Nussbaum T, Samarin J, Ehemann V, Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis. Hepatology 2008;48:146-56
   PubMed Web of Science ®Google Scholar
• Zhang YC, Wang XP, Zhang LY, Effect of blocking IGF-I receptor on growth of human hepatocellular carcinoma cells. World J Gastroenterol 2006;12(25):3977-82
   PubMedGoogle Scholar
• Cohen BD, Baker DA, Soderstrom C, Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871. Clin Cancer Res 2005;11:2063-73
   PubMed Web of Science ®Google Scholar
• Karp DD, Pollak MN, Cohen RB, Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin. J Thorac Oncol 2009;4:1397-403
   PubMed Web of Science ®Google Scholar
• Karp DD, Paz-Ares LG, Novello S, Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer. J Clin Oncol 2009;27:2516-22
   PubMed Web of Science ®Google Scholar
• Ryan PD, Goss PE. The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer. Oncologist 2008;13:16-24
   PubMed Web of Science ®Google Scholar
• Zhang J, Ji J-Y, Yu M, YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nat Cell Biol 2009;11:1444-50
   PubMed Web of Science ®Google Scholar
• Teraishi F, Guo W, Zhang L, Activation of sterile20-like kinase 1 in proteasome inhibitor bortezomib-induced apoptosis in oncogenic K-ras-transformed cells. Cancer Res 2006;66:6072-9
   PubMedGoogle Scholar
• Liu X, Sempere LF, Ouyang H, MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 2010;120:1298-309
   PubMed Web of Science ®Google Scholar
• Cho WJ, Shin JM, Kim JS, miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2. Mol Cells 2009;28:521-7
   PubMed Web of Science ®Google Scholar
• Zhang J, Smolen GA, Haber DA. Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway. Cancer Res 2008;68:2789-94
   PubMedGoogle Scholar
• O'Neill E, Kolch W. Taming the Hippo: Raf-1 controls apoptosis by suppressing MST2/Hippo. Cell Cycle 2005;4:365-7
   PubMed Web of Science ®Google Scholar
• O'Neill E, Rushworth L, Baccarini M, Kolch W. Role of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1. Science 2004;306:2267-70
   PubMed Web of Science ®Google Scholar
• Monia BP, Sasmor H, Johnston JF, Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo. Proc Natl Acad Sci USA 1996;93:15481-4
   PubMed Web of Science ®Google Scholar
• Khazak V, Astsaturov I, Serebriiskii IG, Golemis EA. Selective Raf inhibition in cancer therapy. Expert Opin Ther Targets 2007;11:1587-609
   PubMed Web of Science ®Google Scholar
• Gokhale PC, Zhang C, Newsome JT, Pharmacokinetics, toxicity, and efficacy of ends-modified raf antisense oligodeoxyribonucleotide encapsulated in a novel cationic liposome. Clin Cancer Res 2002;8:3611-21
   PubMed Web of Science ®Google Scholar
• Rudin CM, Marshall JL, Huang CH, Delivery of a liposomal c-raf-1 antisense oligonucleotide by weekly bolus dosing in patients with advanced solid tumors: a Phase I study. Clin Cancer Res 2004;10(21):7244-51
   PubMedGoogle Scholar
• Dritschilo A, Huang CH, Rudin CM, Phase I study of liposome-encapsulated c-raf antisense oligodeoxyribonucleotide infusion in combination with radiation therapy in patients with advanced malignancies. Clin Cancer Res 2006;12:1251-9
   PubMed Web of Science ®Google Scholar
• Kasid U, Dritschilo A. RAF antisense oligonucleotide as a tumor radiosensitizer. Oncogene 2003;22:5876-84
   PubMed Web of Science ®Google Scholar
• Dancey JE. Inhibitors of the mammalian target of rapamycin. Expert Opin Investig Drugs 2005;14:313-28
   PubMed Web of Science ®Google Scholar
• Cinar B, Fang PK, Lutchman M, The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1. EMBO J 2007;26:4523-34
   PubMedGoogle Scholar
• McClatchey AI, Giovannini M. Membrane organization and tumorigenesis-the NF2 tumor suppressor, Merlin. Genes Dev 2005;19:2265-77
   PubMed Web of Science ®Google Scholar
• Ren A, Yan G, You B, Sun J. Down-regulation of mammalian sterile 20-like kinase 1 by heat shock protein 70 mediates cisplatin resistance in prostate cancer cells. Cancer Res 2008;68:2266-74
   PubMedGoogle Scholar
• Graves JD, Gotoh Y, Draves KE, Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J 1998;17:2224-34
   PubMed Web of Science ®Google Scholar
• Lee KK, Ohyama T, Yajima N, MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. J Biol Chem 2001;276:19276-85
   PubMedGoogle Scholar
• Li Y, Pei J, Xia H, Lats2, a putative tumor suppressor, inhibits G1/S transition. Oncogene 2003;22:4398-405
   PubMed Web of Science ®Google Scholar
• Cantor JP, Iliopoulos D, Rao AS, Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity. Int J Cancer 2007;120:24-31
   PubMedGoogle Scholar
• Dallol A, Agathanggelou A, Tommasi S, Involvement of the RASSF1A tumor suppressor gene in controlling cell migration. Cancer Res 2005;65:7653-9
   PubMed Web of Science ®Google Scholar